These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16797343)

  • 1. Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation.
    Lubitz SA; Baran DA; Alwarshetty MM; Zucker MJ; Arroyo LH; Chan M; Courtney MC; Correa R; Spielvogel D; Lansman SL; Gass AL
    Transplant Proc; 2006 Jun; 38(5):1501-6. PubMed ID: 16797343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy associated with a reduced risk of chronic renal failure after cardiac transplantation.
    Lubitz SA; Pinney S; Wisnivesky JP; Gass A; Baran DA
    J Heart Lung Transplant; 2007 Mar; 26(3):264-72. PubMed ID: 17346629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late steroid withdrawal and cardiovascular events in kidney transplant recipients.
    Arnol M; de Mattos AM; Chung JS; Prather JC; Mittalhenkle A; Norman DJ
    Transplantation; 2008 Dec; 86(12):1844-8. PubMed ID: 19104432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with long-term survival following cardiac transplantation.
    Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy is associated with improved outcomes in vascular surgery patients with renal impairment.
    Welten GM; Chonchol M; Hoeks SE; Schouten O; Dunkelgrün M; van Gestel YR; Goei D; Bax JJ; van Domburg RT; Poldermans D
    Am Heart J; 2007 Nov; 154(5):954-61. PubMed ID: 17967603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice.
    Grigioni F; Carigi S; Potena L; Fabbri F; Russo A; Musuraca AC; Coccolo F; Magnani G; Ortolani P; Leone O; Arpesella G; Magelli C; Branzi A
    Transplant Proc; 2006 Jun; 38(5):1507-10. PubMed ID: 16797344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of heart rate as an independent predictor for survival after heart transplantation.
    Anand RG; Reddy MT; Yau CL; Myers L; Amin RR; Stahls PF; Dumas D; Frohlich ED; Ventura HO
    Am J Cardiol; 2009 May; 103(9):1290-4. PubMed ID: 19406274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metaanalysis of statins and survival in de novo cardiac transplantation.
    Mehra MR; Raval NY
    Transplant Proc; 2004 Jun; 36(5):1539-41. PubMed ID: 15251380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.
    Patlolla V; Patten RD; Denofrio D; Konstam MA; Krishnamani R
    J Am Coll Cardiol; 2009 Jan; 53(3):264-71. PubMed ID: 19147043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Patel ND; Yuh DD
    J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
    May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
    Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.
    Wu AH; Ballantyne CM; Short BC; Torre-Amione G; Young JB; Ventura HO; Eisen HJ; Radovancevic B; Rayburn BK; Lake KD; Yancy CW; Taylor DO; Mehra MR; Kubo SH; Fishbein DP; Zhao XQ; O'Brien KD
    Am J Cardiol; 2005 Feb; 95(3):367-72. PubMed ID: 15670546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and the risk of cancer after heart transplantation.
    Fröhlich GM; Rufibach K; Enseleit F; Wolfrum M; von Babo M; Frank M; Berli R; Hermann M; Holzmeister J; Wilhelm M; Falk V; Noll G; Lüscher TF; Ruschitzka F
    Circulation; 2012 Jul; 126(4):440-7. PubMed ID: 22761452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
    Aliabadi AZ; Mahr S; Dunkler D; Grömmer M; Zimpfer D; Wolner E; Grimm M; Zuckermann AO
    Transplantation; 2008 Dec; 86(12):1771-6. PubMed ID: 19104420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
    Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
    Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
    Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.